New drug aims for better, safer sedation in Hospital's sickest patients
NCT ID NCT06222294
Summary
This study tested a new sedative medicine for adults in intensive care who are on breathing machines. The goal was to see if the drug could safely keep patients comfortably calm and at the right level of sedation for most of their treatment time. Researchers compared it to an existing sedative in over 200 patients to measure success rates and safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEDATION IN THE ICU are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510080, China
Conditions
Explore the condition pages connected to this study.